Towards the Dreamed Biomarkers?
- *Corresponding Author:
- Stella Maris Ranuncolo
Av. San Martín 5481
Buenos Aires (C1417DTB), Argentina
Tel: +5411-4580-2800 (281)
E-mail: [email protected]
Received Date: April 15, 2016; Accepted Date: April 18, 2016; Published Date: April 20, 2016
Citation: Ranuncolo SM (2016) Towards the Dreamed Biomarkers? J Mol Biomark Diagn S2:e002. doi:10.4172/2155-9929.S2-e002
Copyright: © 2016 Ranuncolo SM. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Detection and determination of tumor biomarkers are made from tissue and blood collection. During the last decade new biological sources are feasible: circulating tumor cells and circulating nucleic acids. They are composing a new field named as liquid biopsy. The availability of next-generation sequencing and Digital-PCR among other techniques, led to the possibility of getting the most out of this “circulating material” that would mirror the genetic and epigenetic features of the tumor.